Dr. Reddy’s: Drugmaker
Risk to Small Business: 1.206 = Extreme
In yet another attack on a pharmaceutical industry giant, India’s Dr.Reddy’s was crippled by a nasty hacking incident. The producer of vital COVID-19 treatments like remdesivir and favipiravir and expected manufacturer of Russia’s future Sputnik-V COVID-19 vaccine, Dr.Reddy’s was forced to shut operations at several global facilities, just as it was granted permission to begin a second round of human trials for Sputnik-V.
Individual Risk: No personal data was exposed in this incident.
Customers Impacted: Unknown
How it Could Affect Your Customers’ Business: Healthcare targets have been getting nailed with a blizzard of attacks recently. Increasing protection like security awareness training and adding secure identity and access management is a smart move.